Chi and colleagues identified genomic alterations in EED (37%, or 19/52) and SUZ12 (48% or 25/52) in MPNST, alongside frequent somatic alterations in CDKN2A (81%, 42/52) and NF1 (87%, 45/52) [43]. The gene discussed is SUZ12; the disease is malignant peripheral nerve sheath tumor.